You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 2, February 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Identification of Patients at Risk for Anaphylaxis due to Streptokinase

Mark S. Dykewicz, MD; Kris G., MD; Richard Davison, MD; Kerry J. Kaplan, MD; Roy Patterson, MD

Arch Intern Med. 1986;146(2):305-307.


Abstract

• To identify patients at risk for immediate-type allergic reactions to streptokinase, we performed streptokinase skin tests on patients immediately before planned administration of intravenous streptokinase for treatment of acute myocardial infarction. Forty-five patients had negative skin tests and received streptokinase without allergic reaction. One patient had a positive skin test and was given urokinase instead, without incident. Positive skin tests were also present in a patient who had recently had an anaphylactic reaction to streptokinase, and in two physician volunteers who had been sensitized to streptokinase during initial determination of the optimal skin testing dose. Immunoassays for IgE to streptokinase were performed on serum samples from skin-tested patients and volunteers, and on 16 other patients who had not been skin tested but had previously received streptokinase without allergic reactions. The skin test was a sensitive and specific indicator of elevated levels of IgE to streptokinase. We propose that skin testing immediately before streptokinase administration is a practical approach for identifying patients at risk for immediate-type allergic reactions to streptokinase, and its use may possibly prevent anaphylaxis and death.

(Arch Intern Med 1986;146:305-307)



Author Affiliations

From the Sections of Allergy-Immunology (Drs Dykewicz, McGrath, and Patterson) and Critical Care Medicine (Drs Davison and Kaplan), Department of Medicine, Northwestern University Medical School, Chicago.


Footnotes

Accepted for publication May 13,1985.

Reprint requests to Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611 (Dr Patterson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Allergic Reactions to Drugs and Biologic Agents
deShazo and Kemp
JAMA 1997;278:1895-1906.
ABSTRACT  

PREVALENCE OF ANAPHYLACTIC REACTIONS TO APROTININ: ANALYSIS OF TWO HUNDRED FORTY-EIGHT REEXPOSURES TO APROTININ IN HEART OPERATIONS
Dietrich et al.
J. Thorac. Cardiovasc. Surg. 1997;113:194-201.
ABSTRACT | FULL TEXT  

Streptokinase Skin Testing
McClellan and Morse
Arch Intern Med 1986;146:1855-1855.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.